ARTICLE | Company News
Angion, Duke University, Massachusetts General Hospital deal
May 16, 2011 7:00 AM UTC
Angion partnered with the university and the hospital to develop Angion's BB3 for ischemic stroke. The hepatocyte growth factor (HGF) mimetic is in preclinical development for the indication and is i...